Ellie (Alice) Guardino
Publication Details
-
A lower dose of thalidomide is better than a high dose in metastatic renal cell carcinoma.
BJU Int. 2005; (4): 536-9
To conduct a dose-finding trial using a single low dose and dose escalation of a higher dose of thalidomide in patients with metastatic renal cell carcinoma (RCC), and to evaluate the antineoplastic effectiveness of thalidomide as an anti-angiogenic agent on RCC.
Help
Trial Administration